Hyderabad-based pharma player Laurus Labs has received a licence from the Defence Research & Development Organisation (DRDO) for manufacturing and marketing Covid-19 drug 2-Deoxy-D-Glucose (2-DG) in India. The licence to Laurus Labs has been granted by DRDO as part of efforts to make the drug affordable and accessible to patients.
DRDO had recently invited expression of interest (EoI) from other pharma companies for manufacturing this drug and had said it would grant licences to 15 companies on a first-come, first-served basis. Meanwhile, the Council of Scientific & Industrial Research institution Indian Institute of Chemical Technology (CSIR-IICT) has been licencing the know-how for 2-DG synthesis to other companies, including Lee Pharma, Suven Pharma, Anthem Biosciences and Nosch Labs.
Did you know there is a special island in the world where giant tortoises roam…
Did you know that beneath the ocean floor lies one of the most valuable energy…
Chapchar Kut which is the major spring festival of Mizoram and it was celebrated with…
Did you know that in many countries, rivers are not just water sources but the…
The New Income Tax Rules 2026 are notified and which will come into effect from…
The Telangana State government has unveiled the major welfare push in the Telangana Budget of…